Omri Amirav-Drory, Ph.D., is an Israeli-American scientist, serial entrepreneur, and General Partner at NFX, a $1.4B AUM venture firm. A Fulbright postdoc at Stanford (Axel Brunger's lab), he co-founded Genome Compiler — acquired by Twist Bioscience in 2016 — then turned to investing through NFX Bio, backing scientist-founders at the intersection of technology and biology. In 2022 he co-founded Renewal Bio with Prof. Jacob Hanna to commercialize synthetic embryo technology for longevity and regenerative medicine. His overarching thesis — 'The Race to 160' — frames aging as the defining solvable problem of our time.
Pete Flint is a British-born serial entrepreneur and venture capitalist who co-founded Trulia, the real estate search platform that sold to Zillow for $3.5 billion in 2015. Before that, he was part of the founding team at lastminute.com, which IPO'd in London and sold for $1.1 billion. He is now General Partner at NFX, a seed-stage VC firm built around the thesis that network effects drive 70% of all technology value creation. He was awarded an OBE in 2021 for services to entrepreneurship.